Browse studies

Find your next paid study

3,219 recruiting studies matching your filters

Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study

This study evaluates the time spent on obtaining insurance approval and drugs, means of insurance coverage, out-of-pocket costs for patients, and the surgical …

Clinical Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8+5 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Ohio State University Comprehensive Cancer CenterNCT07215988

Phase 2

A Phase 2 Multicenter, Open-Label, Parallel Cohort Expansion Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-Mesenchymal-epithelial Transition Factor (c-MET) Dysregulation

ABN401-003 is a Phase 2 clinical study to assess efficacy, safety, tolerability and pharmacokinetic profile of ABN401 (vabametkib) in specific populations of a…

Advanced Solid Tumors

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Abion IncNCT05541822

Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer

This study evaluates quality of life and utilities following surgical treatment of stage I-IV rectal cancer. This study may help researches learn more about qu…

Rectal AdenocarcinomaStage I Rectal Cancer AJCC v8Stage II Rectal Cancer AJCC v8+11 more

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT02107105

Phase 2

A Phase 2 De-escalation Study of Dabrafenib and Trametinib for Patients With BRAF V600 Mutant Low-Grade Gliomas

This phase II trial studies how well de-escalating the drugs dabrafenib and trametinib works in treating patients with low-grade gliomas that have a BRAF V600 …

BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT07110246

Observational

Assessment of Systematic Health Properties of Pecan Nut Consumption: Gut, Vascular, Metabolic and Cognitive Outcomes

The main goal of this clinical study is to see if consuming pecan nuts will result in improvements in overall body metabolism such as in blood lipids, markers …

Healthy Adults

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, DavisNCT07227259

Rheumatology Patient Registry and Biorepository

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Rheumatic DiseasesAdult Onset Still DiseaseAnkylosing Spondylitis+17 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Yale UniversityNCT04402086

Phase 3

Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder: A Randomized Controlled Trial (NOVASTIM)

The goal of this clinical trial is to study the NiNA System and how it works to treat overactive bladder. Up to 290 participants will be enrolled in the study …

Overactive Bladder (OAB)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

NinaMED Pty LtdNCT07780786

Phase 1

A Phase 1/2a, Open-Label, Dose Escalation and Dose Expansion First-In-Human Study of the Safety, Tolerability, Activity, and Pharmacokinetics of REGN10597 (Anti-PD-1-IL-2RA-IL-2 Fusion Protein) Alone or in Combination With Cemiplimab in Patients With Advanced Solid Organ Malignancies

This study is researching an experimental drug called REGN10597 alone or in combination with another drug called cemiplimab (called "study drug(s)"). The study…

MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Regeneron PharmaceuticalsNCT06413680

Phase 4

A Prospective, Randomized, Double-blind Trial of the Impact of Intraoperative Intravenous Lidocaine Infusion on Total Opioid Requirements in Children Undergoing Surgical Fixation of Upper Extremity Long Bone Fractures Under General Anesthesia

This study is a prospective, randomized, double-blind clinical trial evaluating whether intraoperative intravenous lidocaine infusion (IVLI) reduces opioid req…

Fracture ArmFracture Closed of Lower End of Forearm, UnspecifiedFracture Elbow+4 more

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Nemours Children's ClinicNCT07552766

Phase 1

A Phase 1/2, Open-Label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Preliminary Efficacy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

This is a Phase 1/2, open-label, multicenter, FIH study to evaluate the safety, tolerability, recommended Phase 2 dose (RP2D), PK/PD, and preliminary anti-tumo…

Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor

Estimated

~$150 – $4,200

Actual pay is set by the research site.

InSilico Medicine Hong Kong LimitedNCT06566079

Observational

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)

This trial tests how well personalized ultra fractionated stereotactic adaptive radiotherapy (PULSAR) works together with HyperArc© radiation treatment plannin…

Head and Neck CarcinomaLocalized Head and Neck CarcinomaMetastatic Head and Neck Carcinoma+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Jonsson Comprehensive Cancer CenterNCT06572423

Phase 1

An Investigational Study of CX-801 as Monotherapy and in Combination With PD1 Inhibition in Participants With Solid Tumors

The purpose of this first-in-human study, CTMX-801-101, is to characterize the safety, tolerability, and antitumor activity of CX-801 as monotherapy and in com…

Solid Tumor, Adult

Estimated

~$150 – $4,200

Actual pay is set by the research site.

CytomX TherapeuticsNCT06462794